Policy
-
Policy Matters
The E-Cigarette Regulatory LandscapeThe FDA is taking several steps to restrict and reduce e-cigarette use among youth.
by Carmine S. Leggett, PhD
-
Learning Medicare’s ABCDsMedicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.
by Kate Yandell
-
A Missed ConversationDespite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
In It for the Long HaulDoctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
-
The Return to WorkWhat happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.
by Jen Tota McGivney
-
From the Editor-in-Chief
Measuring a Cancer Drug’s EffectivenessSurrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
by William G. Nelson, MD, PhD
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
-
Policy Matters
Racial and Ethnic Disparities in Multiple Myeloma Clinical TrialsThe AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.
by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD
-
Survivor Profile
Sharing Her StrengthDiagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.
by Lindsey Konkel
-
Robotic Surgery and CancerUsing robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.
by Sue Rochman
